$LFST
LifeStance Health Group, Inc.

2022 Q1 Form 10-Q Financial Statement

#000095017022009328 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $203.1M $143.1M
YoY Change 41.89% 95.79%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $103.4M $32.65M
YoY Change 216.59% 138.99%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.727M $2.609M
YoY Change 119.51% 19.95%
% of Gross Profit
Operating Expenses $267.9M $144.0M
YoY Change 86.06% 113.44%
Operating Profit -$64.85M -$881.0K
YoY Change 7261.07%
Interest Expense $3.441M $8.632M
YoY Change -60.14% -613.81%
% of Operating Profit
Other Income/Expense, Net -$4.153M -$10.56M
YoY Change -60.68% -3083.62%
Pretax Income -$69.00M -$11.44M
YoY Change 503.02% -440.97%
Income Tax -$6.676M -$2.761M
% Of Pretax Income
Net Earnings -$62.33M -$8.682M
YoY Change 617.9% -427.25%
Net Earnings / Revenue -30.69% -6.07%
Basic Earnings Per Share
Diluted Earnings Per Share -$177.6K -$23.24K
COMMON SHARES
Basic Shares Outstanding 374.3M
Diluted Shares Outstanding 350.8K

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.0M $39.49M
YoY Change 188.63%
Cash & Equivalents $114.0M $39.49M
Short-Term Investments
Other Short-Term Assets $54.32M $22.32M
YoY Change 143.39%
Inventory
Prepaid Expenses
Receivables $94.99M $47.77M
Other Receivables $0.00 $0.00
Total Short-Term Assets $263.3M $109.6M
YoY Change 140.28%
LONG-TERM ASSETS
Property, Plant & Equipment $170.9M $70.80M
YoY Change 141.42%
Goodwill $1.229B
YoY Change
Intangibles $291.2M
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.679M $2.926M
YoY Change 25.73%
Total Long-Term Assets $1.695B $1.497B
YoY Change 13.25%
TOTAL ASSETS
Total Short-Term Assets $263.3M $109.6M
Total Long-Term Assets $1.695B $1.497B
Total Assets $1.958B $1.606B
YoY Change 21.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.14M $5.913M
YoY Change 155.98%
Accrued Expenses $95.01M $71.02M
YoY Change 33.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.323M
YoY Change
Total Short-Term Liabilities $125.6M $96.76M
YoY Change 29.81%
LONG-TERM LIABILITIES
Long-Term Debt $177.4M $387.3M
YoY Change -54.2%
Other Long-Term Liabilities $57.49M $15.24M
YoY Change 277.14%
Total Long-Term Liabilities $290.3M $402.5M
YoY Change -27.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $125.6M $96.76M
Total Long-Term Liabilities $290.3M $402.5M
Total Liabilities $415.9M $580.5M
YoY Change -28.36%
SHAREHOLDERS EQUITY
Retained Earnings -$419.4M
YoY Change
Common Stock $1.962B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.543B $1.026B
YoY Change
Total Liabilities & Shareholders Equity $1.958B $1.606B
YoY Change 21.92%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$62.33M -$8.682M
YoY Change 617.9% -427.25%
Depreciation, Depletion And Amortization $5.727M $2.609M
YoY Change 119.51% 19.95%
Cash From Operating Activities $3.308M $9.909M
YoY Change -66.62% 313.56%
INVESTING ACTIVITIES
Capital Expenditures $27.91M $11.08M
YoY Change 151.87% -228.21%
Acquisitions $22.95M $754.0K
YoY Change 2943.1%
Other Investing Activities -$22.95M -$754.0K
YoY Change 2943.1% -91.01%
Cash From Investing Activities -$50.86M -$11.84M
YoY Change 329.7% -30.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $331.0K $785.0K
YoY Change -57.83%
Cash From Financing Activities 13.51M 22.59M
YoY Change -40.21% -28.1%
NET CHANGE
Cash From Operating Activities 3.308M 9.909M
Cash From Investing Activities -50.86M -11.84M
Cash From Financing Activities 13.51M 22.59M
Net Change In Cash -34.04M 20.67M
YoY Change -264.72% 23.07%
FREE CASH FLOW
Cash From Operating Activities $3.308M $9.909M
Capital Expenditures $27.91M $11.08M
Free Cash Flow -$24.60M -$1.172M
YoY Change 1999.15% -110.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001845257
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94991000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76078000
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40478
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 6000
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
CY2022Q1 dei City Area Code
CityAreaCode
602
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
767-2100
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
LFST
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
374323422
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113990000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148029000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
291180000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
54316000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42413000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
263297000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
266520000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
170927000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
300355000
CY2022Q1 us-gaap Goodwill
Goodwill
1229303000
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
CY2022Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3679000
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3448000
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1695089000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1660589000
CY2022Q1 us-gaap Assets
Assets
1958386000
CY2021Q4 us-gaap Assets
Assets
1927109000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15136000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14152000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73207000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60002000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21807000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26510000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13491000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
14123000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1956000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1965000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
125597000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
116752000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
177380000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
157416000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57487000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50325000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1123000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3307000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54281000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54281000
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
290271000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
265329000
CY2022Q1 us-gaap Liabilities
Liabilities
415868000
CY2021Q4 us-gaap Liabilities
Liabilities
382081000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
754000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50855000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374323000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374323000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374255000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374255000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3744000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3743000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1958174000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1898357000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-419400000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357072000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1542518000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1545028000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1958386000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1927109000
CY2022Q1 us-gaap Revenues
Revenues
203095000
CY2021Q1 us-gaap Revenues
Revenues
143132000
CY2022Q1 us-gaap Other General Expense
OtherGeneralExpense
148893000
CY2021Q1 us-gaap Other General Expense
OtherGeneralExpense
99134000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103369000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32651000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15684000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12228000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
267946000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
144013000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-64851000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-881000
CY2022Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-434000
CY2021Q1 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
-307000
CY2022Q1 lfst Transaction Costs
TransactionCosts
278000
CY2021Q1 lfst Transaction Costs
TransactionCosts
-1534000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3441000
CY2021Q1 us-gaap Interest Expense
InterestExpense
8632000
CY2022Q1 us-gaap Other Expenses
OtherExpenses
0
CY2021Q1 us-gaap Other Expenses
OtherExpenses
89000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4153000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10562000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69004000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11443000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6676000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2761000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62328000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8682000
CY2022Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0
CY2021Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62328000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45432000
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.18
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
350849
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
305538
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-62328000
CY2022Q1 lfst Stock Issued During Period Value Restricted Stock Units Releases
StockIssuedDuringPeriodValueRestrictedStockUnitsReleases
-37000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-185000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60040000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1542518000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
997836000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8682000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
CY2021Q1 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
36750000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
605000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
954009000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-62328000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8682000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15684000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12228000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
59855000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
605000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
295000
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
403000
CY2022Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-434000
CY2021Q1 lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
-307000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18121000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3116000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12065000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8042000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1852000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3014000
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
12759000
CY2021Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
7314000
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4943000
CY2021Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
5878000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3308000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9909000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27910000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11081000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
22945000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11835000
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
955000
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
323000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
26200000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
331000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
785000
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
5720000
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1546000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
441000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13508000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22591000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34039000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20665000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18829000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113990000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39494000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3091000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
6806000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-60000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2022Q1 lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
0
CY2021Q1 lfst Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses
1871000
CY2022Q1 lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
57000
CY2021Q1 lfst Equipment Financed Through Capital Leases
EquipmentFinancedThroughCapitalLeases
14000
CY2022Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
2470000
CY2021Q1 lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
808000
CY2022Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
12320000
CY2021Q1 lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
7498000
CY2022Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-01-28
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
284000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
34000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
18000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
64000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
6000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q1 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2022Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
2
CY2021Q1 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
1
CY2022Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
25795000
CY2021Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
1508000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
421000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
782000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
40000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
486000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
3000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Deposits
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedDeposits
5000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
87000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
125000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
24701000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
1117000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
26491000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
1595000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
696000
CY2022Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
25795000
CY2021Q1 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
1508000
CY2022Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
782000
CY2021Q1 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
125000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
363449000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
72269000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
291180000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
362667000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
62312000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
300355000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9957000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9619000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
196180000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
171768000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25253000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19526000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
170927000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
152242000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5727000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2609000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
14614000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
CY2022Q1 lfst Financial Assets And Liabilities Fair Value Recurring
FinancialAssetsAndLiabilitiesFairValueRecurring
0
CY2021Q4 us-gaap Goodwill
Goodwill
1204544000
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
24701000
CY2022Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
58000
CY2022Q1 us-gaap Goodwill
Goodwill
1229303000
CY2020Q2 us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
May 14, 2026
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
180899000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
161230000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1323000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1323000
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2196000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2491000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
177380000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
157416000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3441000
CY2021Q1 us-gaap Interest Expense
InterestExpense
8632000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
992000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
1323000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
1323000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
21323000
CY2022Q1 lfst Long Term Debt Maturities Repayments Of Principal In Rolling Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearSix
155938000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
180899000
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
196950000
CY2021Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
186497000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
203095000
CY2022Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
143132000
CY2021Q1 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6676000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2761000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.097
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.241
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
244356
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 lfst Fair Value Of Mezzanine Equity
FairValueOfMezzanineEquity
36750000
CY2022Q1 lfst Number Of Office Facilities
NumberOfOfficeFacilities
19
CY2022Q1 lfst Lease Expiration Year
LeaseExpirationYear
2030
CY2022Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
387000
CY2021Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
537000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1119000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1198000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1012000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1023000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
144000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
257000
CY2022Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4753000
CY2021Q1 lfst Related Party Management Fees
RelatedPartyManagementFees
89000
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2021Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
17430000
CY2020Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
16414000
CY2022Q1 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
2470000
CY2021 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
10685000
CY2022Q1 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-5720000
CY2021 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-12279000
CY2022Q1 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
434000
CY2021 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
2610000
CY2022Q1 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
14614000
CY2021Q4 lfst Business Combination Contingent Consideration
BusinessCombinationContingentConsideration
17430000
CY2022Q1 lfst Operating Lease Expiration Year
OperatingLeaseExpirationYear
2032
CY2022Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
11159000
CY2021Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
6578000
CY2022Q1 us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
CY2022Q1 us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62328000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45432000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
350849
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
305538
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.18
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.15
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39029

Files In Submission

Name View Source Status
0000950170-22-009328-index-headers.html Edgar Link pending
0000950170-22-009328-index.html Edgar Link pending
0000950170-22-009328.txt Edgar Link pending
0000950170-22-009328-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfst-20220331.htm Edgar Link pending
lfst-20220331.xsd Edgar Link pending
lfst-20220331_cal.xml Edgar Link unprocessable
lfst-20220331_def.xml Edgar Link unprocessable
lfst-20220331_htm.xml Edgar Link completed
lfst-20220331_lab.xml Edgar Link unprocessable
lfst-20220331_pre.xml Edgar Link unprocessable
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending